Novel Agents and Combinations in Hodgkin Lymphoma
0 Vues
• 07/09/23
0
0
Intégrer
administrator
Les abonnés
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires